The store will not work correctly when cookies are disabled.
7-(Isoindolin-4-yl)-4-methylquinolin-2-amine Dihydrochloride
ID: ALA4460322
PubChem CID: 155527878
Max Phase: Preclinical
Molecular Formula: C18H19Cl2N3
Molecular Weight: 275.36
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(N)nc2cc(-c3cccc4c3CNC4)ccc12.Cl.Cl
Standard InChI: InChI=1S/C18H17N3.2ClH/c1-11-7-18(19)21-17-8-12(5-6-14(11)17)15-4-2-3-13-9-20-10-16(13)15;;/h2-8,20H,9-10H2,1H3,(H2,19,21);2*1H
Standard InChI Key: CYZBUGCELOCSLB-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 24 0 0 0 0 0 0 0 0999 V2000
6.3394 -13.9500 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
3.8369 -11.4984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8358 -12.3221 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5479 -12.7352 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5461 -11.0896 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2589 -11.4948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2596 -12.3180 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9723 -12.7292 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6847 -12.3142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6800 -11.4879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9667 -11.0846 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1236 -12.7342 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.5437 -10.2724 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3904 -12.7160 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3930 -13.5343 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1018 -13.9394 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8086 -13.5274 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0926 -12.3045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8006 -12.7023 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3977 -12.1519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.0587 -11.4139 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.2522 -11.5083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0823 -10.4213 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
3 12 1 0
5 13 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 19 1 0
18 14 1 0
9 14 1 0
18 19 2 0
19 20 1 0
20 21 1 0
21 22 1 0
22 18 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 275.36 | Molecular Weight (Monoisotopic): 275.1422 | AlogP: 3.40 | #Rotatable Bonds: 1 |
Polar Surface Area: 50.94 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.16 | CX LogP: 3.37 | CX LogD: 1.52 |
Aromatic Rings: 3 | Heavy Atoms: 21 | QED Weighted: 0.72 | Np Likeness Score: -0.24 |
References
1. Cinelli MA, Reidl CT, Li H, Chreifi G, Poulos TL, Silverman RB.. (2020) First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate., 63 (9): [PMID:32302123] [10.1021/acs.jmedchem.9b01573] |